Bio-Techne Corp. Stock
Price
Target price
€77.00
€77.00
-1.280%
-
-1.280%
€75.94
15.05.24 / Tradegate
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bio-Techne Corp. Stock
A loss of -1.280% shows a downward development for Bio-Techne Corp..
Bio-Techne Corp. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
However, we have a potential of -2.6% for Bio-Techne Corp. as the target price of 75 € is below the current price of 77.0 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -1.280% | 6.944% | 24.194% | 2.667% | 8.451% | - | - |
| Neogen Corp. | 3.540% | 2.632% | -3.306% | -22.517% | -36.066% | -69.412% | -56.294% |
| Bio-Rad Labs Inc. A | 0.960% | 10.817% | -2.227% | -21.197% | -5.790% | -44.234% | - |
| Merit Medical Systems | 2.700% | 3.401% | 13.433% | -1.299% | 11.765% | 54.472% | 53.241% |
Comments
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
